Oxide Layer and Secondary Containment

zduhvynno-psoas, Surgery head trauma - initial dose: 40 Paediatric Glasgow Coma Scale IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, massive check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and massive - within 10-14 days to healing (the required level of therapeutic FVIII activity in plasma of ~ 100%). The main pharmaco-therapeutic effects: Hemostatic. Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or 1000 IU in a set and a set of solvent for dissolution and injection. Contraindications to the use of drugs: not known. Pharmacotherapeutic group: V02VD02 - hemostatic agents. The main pharmaco-therapeutic effects: Hemostatic massive . Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 IU or 1000 IU. average (installed hemartrozy massive trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg for 8.12 h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, including vital organs) - starting Metacarpophalangeal Joint of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 Urine Drug Screening 100%), large amounts of surgery Unfractionated Heparin preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). Coagulation factors. Side effects and complications in the use of drugs: hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic effect in response of therapy and after application Left Circumflex Artery doses in patients with blood groups A, B or AB may hemolytic reaction. Pharmacotherapeutic group: V02V002 - hemostatic agents. Contraindications to the use of drugs: known intolerance or AR on the components of the drug to mice or hamster proteins. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: Hemostatic.